Infinitt Healthcare
| Market cap | ₩255.2B |
| PE ratio | 4.08 |
| Forward PE | – |
| PB ratio | 1.15 |
| EPS | ₩2,629 |
| Dividend (yield) | ₩200 (1.86%) |
| Analysts (1–5) | – |
| Price target | – |
| Volume | 21,343 |
| Trading value | ₩225.0M |
| Day’s range | ₩10,430 – ₩10,690 |
| 52-week range | ₩5,250 – ₩14,080 |
| Foreign ownership KR | 13.22% |
| Foreign net buy (Oct 21) KR | −6,752 sh |
| Book value / share | ₩9,300 |
| Founded | 2002 |
Close (KRW) Foreign ownership, % of shares (right axis)
Foreign, institutional and retail net buying KR data
Shares by trading day; positive means net buying. Korea publishes investor-type flows for every stock — global sites such as Yahoo or StockAnalysis do not show them.
| Date | Close | Foreigners | Institutions | Retail | Foreign ownership |
|---|---|---|---|---|---|
| Oct 21 | ₩10,730 | −6,752 | 0 | +7,132 | 13.20% |
| Oct 20 | ₩10,800 | +4,551 | −1,057 | −3,494 | 13.22% |
| Oct 19 | ₩10,760 | +2,068 | −1,660 | −408 | 13.21% |
| Oct 16 | ₩10,770 | +11,040 | −1,111 | −9,929 | 13.20% |
| Oct 15 | ₩10,200 | +16,025 | 0 | −16,025 | 13.19% |
Financials
Annual, consolidated where available, KRW. Columns ending in E are analyst consensus estimates. Source: company filings (DART) via Naver Finance.
| Item | FY2023 | FY2024 | FY2025 | FY2026E |
|---|---|---|---|---|
| Revenue | ₩85.9B | ₩95.8B | ₩102.4B | – |
| Operating income | ₩3.9B | ₩7.7B | ₩14.2B | – |
| Net income | ₩16.8B | ₩38.5B | ₩26.8B | – |
| Operating margin | 4.59% | 8.07% | 13.88% | – |
| Return on equity | 13.36% | 25.21% | 14.66% | – |
| Debt-to-equity | 30.97% | 29.43% | 27.79% | – |
| EPS | ₩675 | ₩1,549 | ₩1,082 | – |
| Dividend per share | – | – | ₩200 | – |
Peers
| Seers 458870 | ₩26,300 | −5.57% |
| Lunit 328130 | ₩14,650 | −0.27% |
| Sky Labs 386380 | ₩11,010 | +3.09% |
| 3billion 394800 | ₩5,580 | −1.24% |
| GC MediAI 032620 | ₩2,870 | −1.37% |
| Solborn 035610 | ₩4,780 | +0.84% |
About
Infinitt Healthcare develops PACS and 3D medical imaging software, supplying about 6,300 medical institutions in 55 countries. In Korea it holds a 75% share among tertiary hospitals and 70% among general hospitals, and it has launched Korea's first integrated medical data platform combined with AI. Founded in 2002, it listed on the KOSDAQ in 2010 and has 8 overseas subsidiaries, including in the US.
Infinitt Healthcare Co., Ltd. is listed on the KOSDAQ market of the Korea Exchange under the ticker 071200. Industry: Software & game publishing.
Direct KRX access through a global broker, a US-listed ADR where one exists, or a Korea ETF — compared in our guide.
Data: Korea Exchange regular-session closing prices, volume and day’s range via Daum Finance, checked against a Naver Finance snapshot at the close; investor flows, foreign ownership and ratios via Naver Finance; company information from DART (Financial Supervisory Service). Updated after each Korean market close; ratios as of Oct 21, 2026; investor flows as of Oct 21, 2026. Delayed data, not investment advice.